Skip to main content
Top
Published in: BMC Urology 1/2021

Open Access 01-12-2021 | Overactive Bladder | Case report

Bilateral electrical pudendal nerve stimulation as additional therapy for lower urinary tract dysfunction when stage II sacral neuromodulator fails: a case report

Authors: Shan Chen, Siyou Wang, Yunqiu Gao, Xiaolian Lu, Jiasheng Yan, Lihua Xuan, Shenhong Wang

Published in: BMC Urology | Issue 1/2021

Login to get access

Abstract

Background

Sacral neuromodulation (SNM) has become an effective therapy for patients with lower urinary tract dysfunction (LUTD) who do not respond to conservative treatment. However, an effective treatment strategy for patients who fail SNM has not yet been identified. An option for LUTD is needed when the clinical response to the SNM diminishes.

Case presentation

A 51-year-old Chinese man presented to an outpatient clinic complaining of difficulty in urination for > 3 years. The patient also complained of urinary frequency and urgency, accompanied by perineal discomfort. He was diagnosed with LUTD based on his symptoms and previous examinations. The patient underwent sacral neuromodulation with a permanent implantable pulse generator (IPG) (provided free of charge by Chengnuo Medical Technology Co., Ltd.; General Stim, Hangzhou, China) in the left buttock, as he participated in the company’s clinical trial to test the long-term effects of IPG. He reported loss of efficacy of the device 3 months after the implantation. We performed bilateral electrical pudendal nerve stimulation (EPNS) therapy for him. After 2 weeks of treatment, he began to report smooth voiding within 2 h after EPNS, and a moderate improvement in urinary frequency, urgency, and perineal discomfort. After 4 weeks of EPNS, the patient reported > 50% improvement in his urination, evaluated with the short form of the International Consultation on Incontinence Questionnaire for Male Lower Urinary Tract Symptoms. He reported smooth voiding, moderate improvements in urinary frequency and urgency, and the disappearance of the perineal discomfort. He also reported improved sleep and erections. The patient was discharged after 8 weeks of EPNS treatment.

Conclusion

EPNS could be an option as an additional therapy for patients with LUTD who have failed SNM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mcdonough RC, Ryan ST. Diagnosis and management of lower urinary tract dysfunction. Surg Clin N Am. 2016;96:441–52.CrossRef Mcdonough RC, Ryan ST. Diagnosis and management of lower urinary tract dysfunction. Surg Clin N Am. 2016;96:441–52.CrossRef
2.
go back to reference Ammirati E, Giammò A, Manassero A, Carone R. Neuromodulation in urology, state of the art. Urologia. 2019;86:177–82.CrossRef Ammirati E, Giammò A, Manassero A, Carone R. Neuromodulation in urology, state of the art. Urologia. 2019;86:177–82.CrossRef
3.
go back to reference Zhang P, Zhang JZ, Wu LY, Zhang XD. Effects of appropriate prolonged sacral neuromodulation testing in improving implantation rate of a permanent implantable pulse generator in patients with refractory lower urinary tract dysfunctions in mainland China. Chin Med J (Engl). 2017;130:439–44.CrossRef Zhang P, Zhang JZ, Wu LY, Zhang XD. Effects of appropriate prolonged sacral neuromodulation testing in improving implantation rate of a permanent implantable pulse generator in patients with refractory lower urinary tract dysfunctions in mainland China. Chin Med J (Engl). 2017;130:439–44.CrossRef
4.
go back to reference Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA. Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. 2017;36:354–9.CrossRef Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA. Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. 2017;36:354–9.CrossRef
5.
go back to reference Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099–109.CrossRef Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099–109.CrossRef
6.
go back to reference Chen S, Wang S, Xuan Li LuH, Hu Z, Zhang C, et al. Comparison of efficacy and safety between electroacupuncture at “four sacral points” and conventional electroacupuncture for the treatment of urinary incontinence after stroke: study protocol for a randomised controlled trial. BMJ Open. 2018;8:e021783.CrossRef Chen S, Wang S, Xuan Li LuH, Hu Z, Zhang C, et al. Comparison of efficacy and safety between electroacupuncture at “four sacral points” and conventional electroacupuncture for the treatment of urinary incontinence after stroke: study protocol for a randomised controlled trial. BMJ Open. 2018;8:e021783.CrossRef
8.
go back to reference Wang S, Lv J, Feng X, Lv T. Efficacy of electrical pudendal nerve stimulation versus transvaginal electrical stimulation in treating female idiopathic urgency urinary incontinence. J Urol. 2017;197:1496–501.CrossRef Wang S, Lv J, Feng X, Lv T. Efficacy of electrical pudendal nerve stimulation versus transvaginal electrical stimulation in treating female idiopathic urgency urinary incontinence. J Urol. 2017;197:1496–501.CrossRef
11.
go back to reference Banakhar M, Hassouna M. Patients with sacral neuromodulation: what are the factors affecting their therapy satisfaction? Urol Int. 2019;103:450–3.CrossRef Banakhar M, Hassouna M. Patients with sacral neuromodulation: what are the factors affecting their therapy satisfaction? Urol Int. 2019;103:450–3.CrossRef
12.
go back to reference Erdogru T, Onur R. Laparoscopic selective pudendal neuromodulation for neurogenic bladder: a review of literature. Cent Eur J Urol. 2020;73:39–41. Erdogru T, Onur R. Laparoscopic selective pudendal neuromodulation for neurogenic bladder: a review of literature. Cent Eur J Urol. 2020;73:39–41.
13.
go back to reference Wang S, Lv J, Feng X, Wang G, Lv T. Efficacy of electrical pudendal nerve stimulation in treating female stress incontinence. Urology. 2016;91:64–9.CrossRef Wang S, Lv J, Feng X, Wang G, Lv T. Efficacy of electrical pudendal nerve stimulation in treating female stress incontinence. Urology. 2016;91:64–9.CrossRef
14.
go back to reference Wang S, Zhang S, Zhao L. Long-term efficacy of electrical pudendal nerve stimulation for urgency–frequency syndrome in women. Int Urogynaecol J. 2014;25:397–402.CrossRef Wang S, Zhang S, Zhao L. Long-term efficacy of electrical pudendal nerve stimulation for urgency–frequency syndrome in women. Int Urogynaecol J. 2014;25:397–402.CrossRef
15.
go back to reference Marinkovic SP. New technologies in the management of overactive bladder: current research and future prospects. Ther Adv Urol. 2019;11:1756287219844669.CrossRef Marinkovic SP. New technologies in the management of overactive bladder: current research and future prospects. Ther Adv Urol. 2019;11:1756287219844669.CrossRef
16.
go back to reference Li ALK, Marques R, Oliveira A, Veloso L, Girao MJBC, Lemos N. Laparoscopic implantation of electrodes for bilateral neuromodulation of the pudendal nerves and S3 nerve roots for treating pelvic pain and voiding dysfunction. Int Urogynaecol J. 2018;29:1061–4.CrossRef Li ALK, Marques R, Oliveira A, Veloso L, Girao MJBC, Lemos N. Laparoscopic implantation of electrodes for bilateral neuromodulation of the pudendal nerves and S3 nerve roots for treating pelvic pain and voiding dysfunction. Int Urogynaecol J. 2018;29:1061–4.CrossRef
17.
go back to reference Marinkovic SP, Miller B, Hughes S, Marinkovic C, Gillen L. Successful bilateral pudendal neuromodulation to treat male detrusor areflexia following severe pubic symphysis fracture, a case report. BMC Urol. 2015;15:115.CrossRef Marinkovic SP, Miller B, Hughes S, Marinkovic C, Gillen L. Successful bilateral pudendal neuromodulation to treat male detrusor areflexia following severe pubic symphysis fracture, a case report. BMC Urol. 2015;15:115.CrossRef
18.
go back to reference Jottard K, Bonnet P, Bruyninx L, Ploteau S, De Wachter S. The ENTRAMI technique: Endoscopic transgluteal minimal invasive technique for implantation of a pudendal electrode under full visual control: a cadaver study. Neurourol Urodyn. 2019;38:130–4.CrossRef Jottard K, Bonnet P, Bruyninx L, Ploteau S, De Wachter S. The ENTRAMI technique: Endoscopic transgluteal minimal invasive technique for implantation of a pudendal electrode under full visual control: a cadaver study. Neurourol Urodyn. 2019;38:130–4.CrossRef
19.
go back to reference Lee C. Sacral neuromodulation implant infection: risk factors and prevention. Curr Urol Rep. 2017;18:16.CrossRef Lee C. Sacral neuromodulation implant infection: risk factors and prevention. Curr Urol Rep. 2017;18:16.CrossRef
20.
go back to reference Wang S, Chen G, Li L. “Four sacral needles” therapy for female stress incontinence. J Acupunt Tuina Sci. 2006;25:15–7. Wang S, Chen G, Li L. “Four sacral needles” therapy for female stress incontinence. J Acupunt Tuina Sci. 2006;25:15–7.
21.
go back to reference Wang S, Zhang S. Simultaneous perineal ultrasound and vaginal pressure measurement prove the action of electrical pudendal nerve stimulation in treating female stress incontinence. BJU Int. 2012;110:1338–43.CrossRef Wang S, Zhang S. Simultaneous perineal ultrasound and vaginal pressure measurement prove the action of electrical pudendal nerve stimulation in treating female stress incontinence. BJU Int. 2012;110:1338–43.CrossRef
22.
go back to reference Li T, Feng X, Lv J, Cai T, Wang S. Short-term clinical efficacy of electric pudendal nerve stimulation on neurogenic lower urinary tract disease: a pilot research. Urol. 2018;112:69–73.CrossRef Li T, Feng X, Lv J, Cai T, Wang S. Short-term clinical efficacy of electric pudendal nerve stimulation on neurogenic lower urinary tract disease: a pilot research. Urol. 2018;112:69–73.CrossRef
23.
go back to reference Gammie A, Kaper M, Steup A, Yoshida S, Dorrepaal C, Kos T, et al. Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients. Neurourol Urodyn. 2018;37:1501–5.CrossRef Gammie A, Kaper M, Steup A, Yoshida S, Dorrepaal C, Kos T, et al. Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients. Neurourol Urodyn. 2018;37:1501–5.CrossRef
24.
go back to reference Wessells H, Angermeier KW, Elliott S, Gonzalez CM, Kodama R, Peterson AC, et al. Male urethral stricture: American Urological Association guideline. J Urol. 2017;197:182–90.CrossRef Wessells H, Angermeier KW, Elliott S, Gonzalez CM, Kodama R, Peterson AC, et al. Male urethral stricture: American Urological Association guideline. J Urol. 2017;197:182–90.CrossRef
25.
go back to reference Huffman MM, Slack A, Hoke M. Bladder pain syndrome. Prim Care. 2019;46:213–21.CrossRef Huffman MM, Slack A, Hoke M. Bladder pain syndrome. Prim Care. 2019;46:213–21.CrossRef
26.
go back to reference Shim SR, Kim JH, Choi H. General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31:353–65.CrossRef Shim SR, Kim JH, Choi H. General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31:353–65.CrossRef
27.
go back to reference Kelleher C, Hakimi Z, Zur R, Siddiqui E, Maman K, Aballéa S, et al. Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis. Urology. 2018;74:324–33. Kelleher C, Hakimi Z, Zur R, Siddiqui E, Maman K, Aballéa S, et al. Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis. Urology. 2018;74:324–33.
Metadata
Title
Bilateral electrical pudendal nerve stimulation as additional therapy for lower urinary tract dysfunction when stage II sacral neuromodulator fails: a case report
Authors
Shan Chen
Siyou Wang
Yunqiu Gao
Xiaolian Lu
Jiasheng Yan
Lihua Xuan
Shenhong Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2021
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-021-00808-5

Other articles of this Issue 1/2021

BMC Urology 1/2021 Go to the issue